Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This stock is getting a lot of buzz in penny land ... Hearing rumors about to run hard very soon
SVFC in breakout mode
Pretty large volume today!
Great news!
NEW YORK, NY -- (Marketwired) -- 10/07/13 -- IntelliCell Biosciences, Inc. (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous vascular cells (SVC's) derived from the blood vessels, announced today that it has filed its 10Q quarterly report and is now in full compliance with SEC regulations as a fully reporting public company as reflected under the Securities Exchange Act of 1934. Due to the reestablishment of compliance, the company's shares are now trading on the OTCQB exchange.
Dr. Steven Victor, the Chairman and CEO of IntelliCell Biosciences, commented, "We are pleased to announce we have filed our last remaining outstanding quarterly report, which now makes us a fully reporting company. We are gaining tremendous momentum with our stem cell product lines, and believe that now is the ideal time to position the company to attract new investors. Going forward, we will focus our efforts in developing our stem cell technology at our facilities in New York, and other healthcare institutions across the US and internationally."
As of October 02, 2013, there were approximately 140,839,646 common shares issued and outstanding. To review our public filings with the SEC please visit www.sec.gov
About IntelliCell Biosciences
IntelliCell is a pioneering regenerative medicine company focused on the expanding regenerative medical markets using adult autologous vascular cells (SVC's) derived from the blood vessels in the adult adipose tissue. IntelliCell Biosciences has developed its own patent pending protocol to separate adult autologous vascular cells from adipose tissue without the use of enzymes. IntelliCell will also be seeking to develop technology-licensing agreements with technology developers, universities, and international business entities.www.intellicellbiosciences.com
Forward-Looking Statements
Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "will reach," "will change," "will soon," "should," "could," "would," "may," "can" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.
Contact:
IntelliCell Biosciences, Inc.
Investor Relations
Anna Rhodes
Phone: (212) 249-3050
Email: Email Contact
Steven Victor MD
Chairman
Intellicell Biosciences Inc
460 Park Avenue 17th Floor
New York, NY 10022
212-249-3050 Regen Medical PC
Cell 917-459-8252
Email Contact
www.intellicellbiosciences.com
www.regenmedicalpc.com
www.victordermatologyandrejuvenation.com
Source: IntelliCell Biosciences, Inc.
For those who didn't know... The healthcare reform also known as Obamacare started letting people apply for insurance and their policies start January 1st... Part of the reform is that insurance companies will not be able to deny coverage for medical trials... I know because I sell health insurance...
So, imagine the number of medical trials that intellicell will be able to do next year that will be paid by insurance companies
Go SVFC!
I bought more today
In this game u make money and u get out... Greed has always led me to loses before so here I take the cash and be happy
Govt shut down may affect this trade
Why Park Ave? Real estate is so expensive there
Dilution.. Will increase from 340 million shares to 550 million... There is no end to this bottom
EXMT about to break out
EXMT just added a $200,000 client
EXMT just landed $200,000 client
Agreed I sold today
1 month chart bullish
Finally about to dive deep
A big run can only be fueled by short squeeze... This needs to drop heavy before it runs hard
Opportunity for shorts
Agreed... Most respectable brokers do not allow trading after a halt... People won't have the luxury of watching level 2 to sell
Will keep climbing until the a decision is made about the merger
Waiting on the big drop to 10 to buy again
This won't fly until they send another premium email
Get out while u can
Looks like a shorts wrecking ball
Knife coming
I guess we ll just have to watch
Clear skies ahead
It's a fake bid.. APS will pull the bid off when it gets close
U either play APS or let them play you ... U dont leave money on the table
My next entry will be after a 45% dive
APS is not one to hold long... I made 250 on PWEI and now 150 on pcwt because I sold quick.... That's how u play APS. U dont get greedy
True but money is money
Bought at 177 sold at 192. Thank u APS
If they play it right.. I agree
All shorts trapped in PWEI... Smart move
APS is unpredictable... Lesson is to take money when we see it
Sad to say I told u so... Holding an APS or victory mark promo past the 2nd day is pure gamble
Hope u people sold yesterday
Definitely lower risk than buying now at the high of the play
Yes there is always a deep knife